Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIB-IMRT With 5-FU and Mitomycin-C in Locally Advanced Anal Canal Cancer
NCT02701088Phase 2Completed
- Sponsor
- Centre François Baclesse
- Start
- Dec 2015
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, mitomycin c in anal canal carcinoma (SCCA), sponsored by Centre François Baclesse. Started Dec 2015; status: completed.
02
Drugs
fluorouracilmitomycin c
03
Conditions
anal canal carcinoma (SCCA)
Beyond the preview
Go deeper on NCT02701088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02701088.